Ventria Bioscience | GROWTH CAPITAL

Capital Raise

Frontier’s client raised Growth Capital from a private family office


Through internal research and development and collaborations with world-renowned biotech and industry leaders, Ventria created a rich product pipeline with innovative products in human nutrition and human therapeutics.


Ventria was seeking capital to fund additional product development and expansion of its internal capabilities to grow the business.


Frontier was engaged by Ventria to assist the company with securing additional capital to help fund its growth in an abbreviated timeframe. After developing interest and managing a marketing and investment process with several credible investors, an investor with the ability and interest in adding meaningful strategic value made a multi-million dollar investment allowing Ventria to support its efforts to commercialize its various products.

Related Transactions

C2FO raised Growth Capital of $200 Million from preeminent investors: Softbank, Temasek, and USV

Raised Growth Capital of $20 Million with Availability to Additional Capital

Parnell Pharmaceuticals Recapitalized with DW Healthcare and White Oak

Western Container Company successfully consummated a refinancing of its existing debt to fund growth initiatives

MAG Trucks has secured growth financing

InkCycle has successfully completed a refinancing of its senior debt and obtained a bridge loan to fund growth

Southern Theatres, LLC procured a $28 million equity investment from Veronis Suhler Stevenson